If drug companies working in North Carolina and elsewhere get their way in protecting brand-name drugs in a new international trade deal, critics fear that millions of people with AIDS in poor countries will go untreated, losing access to cheaper generics that could keep them alive. Full Story »
Posted by Dwight Rousu
This article is tackling health disparities based on income and geographical location on a global level. By allowing drug patents to remain for twelve years, people are excluding people who are incapable of affording the drugs from receiving them. Generic pharmaceuticals are important for both Americans with low socioeconomic statuses and people afflicted with disease in developing nations. Governments in developing nations do not have the funds to provide the healthcare necessary to maintain a healthy population. Programs like Doctors without Borders help in these areas, but these programs are funded with limited resources as well. Spending $10,000 a year to treat one AIDS patient is not seen as a wise way of spending money, ... More »
Retrieving Comments
